Iron is an essential metal for numerous cellular functions including DNA synthesis and electron transfer reactions. Transferrin receptor TfR 1 is a membrane protein that mediates iron uptake by cells via the iron-binding protein, transferrin 1 . Iron availability controls TfR1 expression at the post-transcriptional level in many cell types, with TfR1 upregulated by iron starvation and downregulated by iron overloading 2 . In contrast, TfR1 mRNA levels depend on the proliferation status in erythroid cells, rather than the intracellular iron status 3 .
been associated with certain features of hematological malignancies including malignant lymphoma, acute myeloid leukemia AML , and acute lymphocytic leukemia 4 6 , while TfR1 on the surface of tumor cells is a molecular target for cancer therapy 7, 8 .
In 1999, Kawabata et al 9 cloned a second TfR-like molecule, called TfR2. TfR2 is a type II membrane protein that has two isoforms, alpha and beta 9 . In normal tissues, most cell types express TfR1 except mature erythrocytes and terminally differentiated cells. In contrast, TfR2-alpha transcripts are mainly detected in hepatocytes, and rather than being regulated by intracellular iron levels, TfR2 expression accords with the cell cycle 10, 11 . Although TfR2 has a lower af nity for transferrin than TfR1 and thus mediates less iron uptake into cells, TfR2-alpha supports the proliferation of TfR1-de cient cells, indicating an important role for TfR2 in tumor cell proliferation 12 . Human cancer cell lines were recently shown to express substantial levels of TfR2-alpha mRNA 13 . High levels of TfR2-alpha mRNA were also reported in AML patient samples 14 , although there was no signi cant association of this nding with French-American-British FAB subtypes of AML, the attainment of complete remission, incidence of relapse, or survival. In contrast, we previously associated the levels of TfR2 mRNA especially the alpha form with survival in AML 15 .
Precise analysis comparing the expression patterns of TfR1 and TfR2 with clinical features in patients with hematological malignancies has yet to be performed. This study analyzed TfR1 and TfR2-alpha mRNA expression in 146 patients with various types of hematological malignancies, including AML, myelodysplastic syndrome MDS , chronic lymphocytic leukemia CLL , and chronic myeloid leukemia CML in the chronic phase CML cp .
Idiopathic thrombocytic purpura, hemolytic crisis of hereditary spherocytosis HS crisis , and autoimmune hemolytic anemia AIHA , which predominantly involves mature erythroblasts, were also included to compare hematological benign disease with leukemias. FISH , in addition to G-banding at the time of diagnosis. Normal peripheral blood PB mononuclear cells PBMNC were obtained from 5 healthy volunteers, who provided informed consent in accordance with the modified Declaration of Helsinki. Three cases AML M2 t 8 ; 21 , AML M5 and CLL showed no TfR2alpha mRNA expression and these data were excluded from the subsequent statistical analysis.
Patients and Methods

Patient samples
Real-time PCR
PBMNC were isolated by mixing heparinized PB cells or BM aspirates with equal Two oligonucleotides labeled with different uorophores were hybridized to the ampli ed fragment during the annealing phase. Two probes coming into close proximity were visualized by the uorescence resonance energy transfer FRET produced between the two uorophores, with the emitted uorescence measured by the LightCycler instrument. Hybridization probes were displaced in different cycles, and this cycle was used as the crossing point.
Standard curves for quanti cation were made by preparing 10-fold serial dilutions of the plasmid containing the human TfR1 and human TfR2-alpha PCR products. To normalize for differences in the amount of total RNA added to each reaction, the human GAPDH housekeeping gene was simultaneously processed in the same sample as an internal control.
The levels of TfR1 mRNA and TfR2-alpha mRNA were determined after multiplication by the relative ratio, which was calculated by dividing the level of human GAPDH mRNA in each sample by the level of human GAPDH mRNA in the K562 cells.
Statistical analysis
The distribution of expression levels of TfR1 and TfR2-alpha mRNA showed a bias. We therefore used logarithmically transformed TfR1 and TfR2-alpha mRNA levels in all samples for subsequent analysis ln_TfR1 and ln_TfR2-alpha, respectively, Table 2 Table 4 .
Discussion
Iron is an essential metal element for many processes in the body, including oxidationreduction reactions, cell proliferation, and apoptosis 17 . Transferrin-bound iron diferric trans- ferrin in blood is imported into intracellular endosomes via TfR1 on the cell membrane for use in various bioactivities 18 . Iron is also considered essential for proliferation in tumor cells, although many aspects of iron metabolism in tumor cells are unclear 19 . High levels of TfR1 have been found in tumor cell lines and in clinical samples of hematological malignancies, but the relationships between TfR expression and clinical features, disease speci city, or prognosis remain to be determined 20, 21 .
TfR2 has recently come under close scrutiny due to its proposed role speci cally in iron transport for cell proliferation, rather than for maintenance of intracellular iron concentrations 22 . Expression of TfR2 is relatively low in hematological tumor cell lines, except for K562 and HEL, which can be induced to differentiate to erythroid cells by hemin. However, TfR2 is abundant in malignant tumors such as ovarian tumor, colorectal cancer, and glioblastoma 13 . A high expression of TfR2 and a low expression of TfR1 has also been demonstrated at the protein level in cancer cells. By contrast, we observed a positive correlation between the levels of TfR1 and TfR2-alpha mRNA expression in cells from patients with hematological malignancies. This difference suggested that the incorporation of iron and / or intracellular iron metabolism might differ between hematological cells or hematological malignancies and solid tumors. The present study confirmed a higher expression of TfR2 in erythroleukemia M6 than in K562 cells, while BM samples obtained from patients with either HS crisis or AIHA showed high levels of both TfR1 and TfR2-alpha mRNA.
These data implicated an important role for TfR2-alpha in heme synthesis in hematopoietic tumor cells and normal erythroblasts.
Low levels of TfR1 and TfR2-alpha mRNA were observed in monocytoid cell diseases, such as AML M5, FAB and CMML FAB , while diseases with more mature monocytoid cells, such as M5b and CMML, showed lower TfR mRNA levels than M5a FAB . Cytokines such as interferon-reduced TfR1 mRNA levels in monocytic leukemia cells in vitro, However, these reports were not widely accepted because of concern regarding the compatibility of the TfR antibodies that were used. Furthermore, Taetle et al 26 showed that TfR1independent iron transport could support leukemic cell growth under some circumstances in vitro, and that such cells contained a log-fold higher concentration of intracellular ferritin and decreased expression of TfR1 26 . Thus, our results implied the TfR-independent uptake into leukemia cells and the presence of a feedback mechanism to maintain intracellular iron status in myeloid leukemia cells.
In conclusion, the present study suggested that TfR1 and TfR2-alpha mRNA do not necessarily correlate with TfR1 and TfR2-alpha protein expression in hematological cells. It follows therefore that TfR mRNA stability is controlled by iron-responsive elements in the mRNA itself. TfR1 and TfR2-alpha mRNA levels were different among FAB subtypes, with high levels found in AML M6 and low levels in monocytic cell diseases, such as AML M5a, M5b and CMML. An inverse relationship was also observed between WBC count and TfR1 or TfR2-alpha mRNA level. Further studies will be necessary to clarify the role s of TfRs in regulating iron metabolism in hematological cells. 
